论文部分内容阅读
二尖瓣球囊扩张术(PTBMV)是目前治疗风心病二尖瓣狭窄有效方法之一,而且以成功率达到93%以上。近期疗效满意,同时与外科手术相比具有并发症少,感染机会少,栓塞率和死亡率低,费用少等优点而成为代替部分外科手术的良好方法[1]。但国内外对PTBMV术后远期疗效尤其再狭窄(RS)的研究
Mitral balloon dilatation (PTBMV) is currently one of the effective methods for the treatment of rheumatic mitral stenosis, and with a success rate of 93% or more. Recent results are satisfactory, and compared with surgery less complications, less chance of infection, low embolic and mortality rates, low cost and become a good alternative to some surgical procedures [1]. But at home and abroad PTBMV long-term efficacy of restenosis (RS) research